Jazz Pharmaceuticals PLC (JAZZ)
110.78
-0.44
(-0.40%)
USD |
NASDAQ |
Apr 30, 16:00
110.78
0.00 (0.00%)
After-Hours: 17:24
Jazz Pharmaceuticals Cash from Financing (TTM): -305.25M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -305.25M |
| September 30, 2023 | -185.35M |
| June 30, 2023 | -395.91M |
| March 31, 2023 | -288.47M |
| December 31, 2022 | -529.49M |
| September 30, 2022 | -795.70M |
| June 30, 2022 | -971.82M |
| March 31, 2022 | 3.681B |
| December 31, 2021 | 3.971B |
| September 30, 2021 | 4.273B |
| June 30, 2021 | 4.716B |
| March 31, 2021 | 694.03M |
| December 31, 2020 | 528.07M |
| September 30, 2020 | 384.42M |
| June 30, 2020 | 387.61M |
| March 31, 2020 | -311.08M |
| December 31, 2019 | -293.74M |
| September 30, 2019 | -652.42M |
| June 30, 2019 | -646.93M |
| March 31, 2019 | -561.90M |
| December 31, 2018 | -479.13M |
| September 30, 2018 | -72.66M |
| June 30, 2018 | -31.66M |
| March 31, 2018 | -275.01M |
| December 31, 2017 | -409.11M |
| Date | Value |
|---|---|
| September 30, 2017 | -541.17M |
| June 30, 2017 | 327.02M |
| March 31, 2017 | 511.77M |
| December 31, 2016 | 540.99M |
| September 30, 2016 | 589.17M |
| June 30, 2016 | -400.48M |
| March 31, 2016 | -363.52M |
| December 31, 2015 | -214.32M |
| September 30, 2015 | -100.90M |
| June 30, 2015 | 256.79M |
| March 31, 2015 | 210.11M |
| December 31, 2014 | 711.03M |
| September 30, 2014 | 692.75M |
| June 30, 2014 | 383.76M |
| March 31, 2014 | 470.67M |
| December 31, 2013 | -23.86M |
| September 30, 2013 | 8.457M |
| June 30, 2013 | 48.69M |
| March 31, 2013 | 469.89M |
| December 31, 2012 | 448.53M |
| September 30, 2012 | 447.74M |
| June 30, 2012 | 419.62M |
| March 31, 2012 | -48.32M |
| December 31, 2011 | -33.08M |
| September 30, 2011 | -35.62M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-971.82M
Minimum
Jun 2022
4.716B
Maximum
Jun 2021
697.81M
Average
-288.47M
Median
Mar 2023
Cash from Financing (TTM) Benchmarks
| Alkermes PLC | -289.71M |
| Endo International PLC | -604.63M |
| Medtronic PLC | -6.981B |
| Perrigo Co PLC | -187.20M |
| Iterum Therapeutics PLC | 1.034M |